OpenAlex
PricingAboutJobs
Log inGet started
Work

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

HTML

Year: 2009
Type: article
Source: European Journal of Pharmaceutics and Biopharmaceutics
DOI: 10.1016/j.ejpb.2009.03.006
Authors: Lieven Baert, Gerben van ‘t Klooster, Willy Dries, Marc François, Alfons Wouters, Esther Basstanie, Koen Iterbeke, Fred Stappers, Paul Stevens, Laurent Schueller, Pieter Van Remoortere, Guenter Kraus, Piet Wigerinck, Jan Rosier
Language: English

Topic: Nanoparticle-Based Drug Delivery
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Keywords: rilpivirine, long-acting injectables, nanoparticle suspensions, non-nucleoside reverse transcriptase inhibitors, HIV treatment, sustained drug release, wet milling, particle size, subcutaneous injection, intramuscular injection, surfactants, pharmacokinetics, antiretroviral drugs
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2056424254
FWCI: 5.913
Cites: 26
Cited by: 237
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms